CELH
Celsius Holdings, Inc.
CELH's fundamentals are strong and it looks cheap: trading at 35x earnings, less than half its usual 142x. Analysts expect strong earnings growth, though they disagree widely on how much.
LXEH
Lixiang Education Holding Co., Ltd.
There isn't enough reported data to score LXEH yet.
CELH Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Stable | |
| Strong |
CELH's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
LXEH Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Under pressure | |
| Unavailable | |
| Strong |
LXEH's balance sheet is currently strong, but its profitability is under pressure. There isn't enough data to rate its revenue and cash flow.
CELH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 21x | $31.89 | — |
| Current | 35x | $31.89 | — |
| Cheap | 40x | $35.95 | +13% |
| Fair | 141x | $127 | +299% |
| Expensive | 650x | $585 | +1735% |
Historical ranges are pointers, not guarantees.
CELH's PE is in its cheap range at 35x. If earnings grow as analysts expect, today's price would be 21x next year's earnings.
LXEH PE Valuation
LXEH has no meaningful PE right now: it lost money over the past year.
CELH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for CELH, with profitability improving. However, they disagree widely on these estimates.
LXEH Forward outlook
There aren't enough analyst estimates for LXEH to show an outlook.
CELH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.53 | +70% |
| Q3 2026 | $0.90 | +718% |
| Q2 2026 | $0.24 | -37% |
| Q1 2026 | $0.43 | +30% |
| Q4 2025 | $0.25 | -44% |
| Q3 2025 | $0.11 | -85% |
| Q2 2025 | $0.38 | -62% |
| Q1 2025 | $0.33 | -64% |
| Q4 2024 | $0.45 | -42% |
CELH has the edge over LXEH in the latest year-over-year earnings comparison.
LXEH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q4 2024 | -$0.32 | +$48.04 |
| Q4 2023 | -$48.36 | -$44.85 |
| Q4 2022 | -$3.51 | +$106.26 |
| Q4 2021 | -$109.77 | -690% |
LXEH has swung to a loss: it lost $0.32 per share over the past year, after a profit the year before.
CELH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $847.2M | +17% |
| Q2 2026 | $817.9M | +11% |
| Q1 2026 | $782.6M | +138% |
| Q4 2025 | $721.6M | +117% |
| Q3 2025 | $725.1M | +173% |
| Q2 2025 | $739.3M | +84% |
| Q1 2025 | $329.3M | -7.4% |
| Q4 2024 | $332.2M | -4.4% |
CELH has the edge over LXEH in the latest year-over-year revenue comparison.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +31 points |
| Q2 2026 | 9.2% | -10 points |
| Q1 2026 | 18% | +2 points |
| Q4 2025 | 3.6% | +9.2 points |
| Q3 2025 | -11% | -9.8 points |
| Q2 2025 | 19% | -4.1 points |
| Q1 2025 | 16% | -7.6 points |
| Q4 2024 | -5.6% | -23 points |
CELH has the edge over LXEH on profitability, with a higher operating margin.
LXEH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q4 2025 | $4.6M | -6% |
| Q4 2024 | $4.9M | -35% |
| Q4 2023 | $7.6M | +3.3% |
| Q4 2022 | $7.4M | +43% |
| Q4 2021 | $5.2M | -78% |
CELH has the edge over LXEH in the latest year-over-year revenue comparison.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -68% | +21 points |
| Q4 2025 | -118% | -114 points |
| Q4 2024 | -79% | -95 points |
| Q4 2023 | -215% | N/A |
| Q4 2022 | -88% | N/A |
| Q4 2021 | -3.8% | N/A |
| Q4 2020 | 16% | N/A |
LXEH's operating margin was −68% last quarter, up 21 points from the same quarter a year ago.
CELH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $127.7M | -60% |
| Q2 2026 | $205.5M | +479% |
| Q1 2026 | $65.8M | -32% |
| Q4 2025 | -$130M | -285% |
| Q3 2025 | $321.5M | +3599% |
| Q2 2025 | $35.5M | +17% |
| Q1 2025 | $96.4M | -26% |
| Q4 2024 | $70.3M | +16394% |
CELH still generates free cash flow, though less than at its 2025 peak: $269M over the past year.
LXEH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q4 2025 | -$47.2M | -$44.4M |
| Q4 2024 | -$2.8M | +$6.4M |
| Q4 2023 | -$9.2M | -255% |
| Q4 2022 | $6M | +40% |
| Q4 2021 | $4.3M | -22% |
LXEH and CELH do not have enough comparable growth data to identify a winner.
CELH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.8% | -2M shares |
| 1 year | -1.1% | -2.9M shares |
| 3 years | +7.4% | +17.6M shares |
| 5 years | +8.3% | +19.5M shares |
| Available history | +32% | +62.4M shares |
CELH has the edge over LXEH on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $300,000 |
| Q2 2026 | $1M |
| Q1 2026 | $8.8M |
| Q4 2025 | $2.5M |
| Q3 2025 | $448,000 |
| Q2 2025 | $879,000 |
| Q1 2025 | $1.9M |
| Q4 2024 | $603,000 |
CELH spent $13M buying back its own shares over the past year, about three times what it spent the year before.
LXEH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +2869% | +11.3M shares |
| 1 year | +4208% | +11.4M shares |
LXEH has 12M diluted shares, up 4208% from a year ago.
CELH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.1x | Net Cash |
| Q2 2026 | 0.2x | Very low |
| Q1 2026 | 0.5x | Very low |
| Q4 2025 | 1.6x | Healthy |
| Q3 2025 | 0.5x | Very low |
| Q2 2025 | 1.4x | Healthy |
| Q1 2025 | -7.3x | Net Cash |
| Q4 2024 | -5.5x | Net Cash |
CELH has more cash than debt.
LXEH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q4 2021 | -15.2x | Net Cash |
| Q4 2020 | -5.0x | Net Cash |
LXEH has more cash than debt.
CELH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.3 | Neutral |
| Stochastic | 56.8 | Neutral |
CELH's weekly RSI is 51 (neutral) and its Stochastic is 57 (neutral).
LXEH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 39.4 | Neutral |
| Stochastic | 10.3 | Oversold |
LXEH's weekly RSI is 39 (neutral) and its Stochastic is 10 (oversold).
CELH PE vs Consumer Defensive Sector
| Metric | CELH | Sector median | Relative |
|---|---|---|---|
| PE | 35x | 19x | 82% above |
| PE % | 11 | 18 | 7 pts below |
CELH is trading at 35x earnings, a 82% premium to the Consumer Defensive sector's median of 19x.
LXEH PE vs Consumer Defensive Sector
| Metric | LXEH | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 19x | — |
LXEH has no meaningful PE right now: it lost money over the past year.
CELH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.1 | 9.4% above |
| 20 week MA | $29.6 | 7.8% above |
| 50 week MA | $36.1 | 12% below |
| 100 week MA | $38.8 | 18% below |
| 200 week MA | $44.6 | 29% below |
CELH has the edge over LXEH on trend strength, trading above more of its moving averages.
LXEH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.49 | 13% below |
| 20 week MA | $1.55 | 16% below |
| 50 week MA | $1.79 | 27% below |
| 100 week MA | $23.3 | 94% below |
| 200 week MA | $86.2 | 98% below |
LXEH is in a downtrend: it's below all five of its weekly moving averages, and 98% below its 200-week average.
CELH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $1.58 | $14.7 | +832% |
| 2021 | $14.7 | $24.9 | +69% |
| 2022 | $24.9 | $35.6 | +43% |
| 2023 | $35.6 | $54.5 | +53% |
| 2024 | $54.5 | $26.5 | -51% |
| 2025 | $26.5 | $45.6 | +72% |
| 2026 YTD | $45.6 | $31.9 | -30% |
CELH has the edge over LXEH on returns for 2026, with the stronger performance.
LXEH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $1,120.0 | $1,692.0 | +51% |
| 2021 | $1,692.0 | $1,800.0 | +6.4% |
| 2022 | $1,800.0 | $560.0 | -69% |
| 2023 | $560.0 | $220.0 | -61% |
| 2024 | $220.0 | $51.3 | -77% |
| 2025 | $51.3 | $2.35 | -95% |
| 2026 YTD | $2.35 | $1.30 | -45% |
LXEH has finished four years in a row lower, and it's down 45% so far in 2026.